
    
      New patients who are eligible for hormonal therapy will be selected.

      They will be allocated randomly into 2 different groups, each group being prescribed 1 of 2
      regimens of hormonal therapy:

        -  17 beta estradiol 1mg/day plus oral micronized progesterone 100mg/day

        -  17 beta estradiol 1mg/day plus dydrogesterone 10mg/day Patients will have their sleeping
           quality accessed using the Pittsburgh sleep quality index(PSQI) at their 1st visit and
           once a month for 3 months. The first and third PSQI score will be analysed.
    
  